Neuroimmunology
Ocrelizumab
Mar. 17, 2021
This is an image preview.
Start a Free Account
to view the full image.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Pathogenic mechanisms of neurodegenerative diseases and neuroprotective effects of different forms of vitamin D3 in experimental models of Alzheimer and Parkinson diseases
Ab--amyloid b; BDNF--brain-derived neurotrophic factor; DA--dopamine; DAT--dopamine transporter; DOPAC--3,4-dihydroxyphenylacetic acid; GDNF--glial-derived neurotrophic factor; HVA--homovanillic acid; NGF--nerve growth factor; ROS--reactive oxygen species; Syn--synuclein; TH--tyrosine kinase; VDR-- the vitamin D receptor. (Source: Lasoń W, Jantas D, Leśkiewicz M, Regulska M, Basta-Kaim A. The vitamin D receptor as a potential target for the treatment of age-related neurodegenerative diseases such as Alzheimer's and Parkinson's diseases: a narrative review. Cells 2023;12[4]:660. Creative Commons Attribution [CC BY] license, creativecommons.org/licenses/by/4.0.)